Title

Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial
A Multi-centre Randomised Double Blinded Phase III Trial of the Effect of Standard Issue Red Blood Cell Blood Units on Mortality Compared to Freshest Available Red Blood Cell Units
  • Phase

    Phase 3
  • Study Type

    Interventional
  • Study Participants

    4994
In Australia, blood for transfusion has a "use by" date of 42 days after collection. The actual age of blood given to patients depends on what is available at the time and the rate of usage. During the last decade, it has been reported that blood transfusion in patients admitted to intensive care was associated with an independent increase of mortality. Some research suggests that transfusion of fresher blood might help patients in the intensive care unit to reach a better recovery. This project will test whether patients who receive 'fresher' blood do better than patients who receive 'standard issue' blood.
Inclusion criteria

•Patients hospitalised in ICU with an anticipated ICU stay of at least 24 hours, in whom the decision has been made by medical staff to transfuse at least one RBC unit.

Exclusion criteria

Age younger than 18
Previous RBC transfusion during the current hospital admission (including transfusion in another hospital for transferred patients)
Diagnosis of transplantation or hematologic diseases
Pregnancy
Cardiac surgery during the present hospital admission
Expected to die imminently (<24hrs)
The treating physician believes it is not in the best interest of the patient to be randomised in this trial.
Known objection to the administration of human blood products
Participation in a competing study

Primary outcome- 90 day mortality

Secondary outcomes

28 day mortality
Persistent Organ Dysfunction combined with death at 28
Days alive and free of mechanical ventilation at day 90 post randomisation
Day alive and free of renal replacement therapy at day 90 post randomisation
Blood stream infection in ICU (post randomisation) defined using the Center for Disease Control and Prevention/National Healthcare Safety Network criteria
Length of stay in ICU and in hospital post randomisation
Febrile non-haemolytic transfusion reactions
EQ-5D score at Day 90 post randomisation
Study Started
Oct 31
2012
Primary Completion
Apr 30
2017
Study Completion
Jun 30
2017
Results Posted
Oct 22
2020
Last Update
Oct 22
2020

Other Blood transfusion

Blood transfusion in ICU patients aged 18 and over.

Standard of care Active Comparator

Blood Transfusion Standard of care- oldest blood.

Arm B Other

Blood Transfusion Freshest blood.

Criteria

Inclusion Criteria:

Patients hospitalised in ICU with an anticipated ICU stay of at least 24 hours, in whom the decision has been made by medical staff to transfuse at least one RBC unit.

Exclusion Criteria:

Age younger than 18
Previous RBC transfusion during the current hospital admission (including transfusion in another hospital for transferred patients)
Diagnosis of transplantation or hematologic diseases
Pregnancy
Cardiac surgery during the present hospital admission
Expected to die imminently (<24hrs)
The treating physician believes it is not in the best interest of the patient to be randomised in this trial.
Known objection to the administration of human blood products
Participation in a competing study (see below)

Summary

Arm B (Short Term Storage)

Standard of Care (Long Term Storage)

All Events

Event Type Organ System Event Term Arm B (Short Term Storage) Standard of Care (Long Term Storage)

Mortality at Day 90

Mortality at Day 90

Arm B (Short Term Storage)

All patients

610.0
participants

APACHE III risk of Death <21.5%

152.0
participants

APACHE III risk of Death =or>21.5%

457.0
participants

Baseline SOFA score >7

400.0
participants

Baseline SOFA score = or < 7

210.0
participants

Group O

264.0
participants

Non-Group O

346.0
participants

Standard of Care (Long Term Storage)

All patients

594.0
participants

APACHE III risk of Death <21.5%

169.0
participants

APACHE III risk of Death =or>21.5%

425.0
participants

Baseline SOFA score >7

403.0
participants

Baseline SOFA score = or < 7

191.0
participants

Group O

259.0
participants

Non-Group O

335.0
participants

Persistent Organ Dysfunction Combined With Death Measured at Day 28

Persistent Organ Dysfunction combined with death measured at day 28

Arm B (Short Term Storage)

Standard of Care (Long Term Storage)

Days Alive and Free of Mechanical Ventilation

Days alive and free of mechanical ventilation

Arm B (Short Term Storage)

25.0
days (Median)
Inter-Quartile Range: 11.0 to 28.0

Standard of Care (Long Term Storage)

25.0
days (Median)
Inter-Quartile Range: 13.0 to 28.0

Day Alive and Free of Renal Replacement Therapy.

Day alive and free of renal replacement therapy.

Arm B (Short Term Storage)

28.0
days (Median)
Inter-Quartile Range: 22.0 to 28.0

Standard of Care (Long Term Storage)

22.0
days (Median)
Inter-Quartile Range: 22.0 to 28.0

Blood Stream Infection in ICU (Post Randomisation)

Blood stream infection in ICU (post randomisation) Time Frame is in Days

Arm B (Short Term Storage)

Standard of Care (Long-term Storage)

Length of Stay in ICU and in Hospital Post Randomisation (Days)

Median duration in ICU - short term storage group was 4.2 (2.0 - 9.3), long term storage group was 4.2 (1.9 - 9.4) Median duration in Hospital - short term storage group was 14.5 (7.4 - 27.5), long term storage group was 14.7 (7.4 - 28.3) In Days

Arm B (Short Term Storage)

Days in Hospital

14.5
Days (Median)
Inter-Quartile Range: 7.4 to 27.5

Days in ICU

4.2
Days (Median)
Inter-Quartile Range: 2.0 to 9.3

Standard of Care (Long Term Storage)

Days in Hospital

14.7
Days (Median)
Inter-Quartile Range: 7.4 to 28.3

Days in ICU

4.2
Days (Median)
Inter-Quartile Range: 1.9 to 9.4

Proportion of Patients Who Suffer at Least One Febrile Non-haemolytic Transfusion Reaction in ICU

Proportion of patients who suffer at least one febrile non-haemolytic transfusion reaction in ICU

Arm B (Short Term Storage)

Standard of Care (Long-term Storage)

Mortality at Day 28

Mortality at day 28

Arm B (Short Term Storage)

Standard of Care (Long Term Storage)

EuroQol-5Dimension 5 Level (EQ-5D-5L) Score at Day 180 Post Randomisation

EuroQol-5Dimension 5 level (EQ-5D-5L) score at day 180 post randomisation - not reported yet

Outcome Measure Data Not Reported

Total

4919
Participants

Age, Continuous

62.0
years (Median)
Standard Deviation: 17.1

APACHE III

72.9
units on a scale (Median)
Standard Deviation: 29.4

Haemoglobin at Admission to ICU

102
g/liter (Median)
Standard Deviation: 23.3

Haemoglobin at randomisation

77.3
g/liter (Median)
Standard Deviation: 12.9

Race and Ethnicity Not Collected

0
Participants

SOFA Score

7
units on a scale (Median)
Inter-Quartile Range: 5.0 to 10.0

ABO Blood group

Primary Diagnosis

Sex: Female, Male

Overall Study

Arm B (Short Term Storage)

Standard of Care (Long-term Storage)